Single-lung transplantation for pulmonary vascular disease.
Six patients with end-stage pulmonary vascular disease received right SLTs. Though patients generally had difficult early postoperative courses, four of the six have survived from 3 to 23 months and have achieved good recovery of right ventricular function and good functional results. SLT is a viable option in selected patients with severe pulmonary hypertension even when right ventricular function is severely impaired.
Maurer
J R
JR
Department of Medicine, University of Toronto, Ontario, Canada.
Winton
T L
TL
Patterson
G A
GA
Williams
T R
TR
D005260:Female; D006439:Hemodynamics; D006801:Humans; D008168:Lung / Q000098:blood supply; D008171:Lung Diseases / Q000601:surgery*; D016040:Lung Transplantation / Q000502:physiology; D012129:Respiratory Function Tests